Fawsitt, C. G., Pan, J., Orishaba, P., Jackson, C. H., & Thom, H. Unanchored simulated treatment comparison on survival outcomes using parametric and Royston-Parmar models with application to lenvatinib plus pembrolizumab in renal cell carcinoma. BMC.
Chicago Style (17th ed.) CitationFawsitt, Christopher G., Janice Pan, Philip Orishaba, Christopher H. Jackson, and Howard Thom. Unanchored Simulated Treatment Comparison on Survival Outcomes Using Parametric and Royston-Parmar Models with Application to Lenvatinib Plus Pembrolizumab in Renal Cell Carcinoma. BMC.
MLA (9th ed.) CitationFawsitt, Christopher G., et al. Unanchored Simulated Treatment Comparison on Survival Outcomes Using Parametric and Royston-Parmar Models with Application to Lenvatinib Plus Pembrolizumab in Renal Cell Carcinoma. BMC.